Detailed answers about SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC, including incorporation, status, business activity, and accounts information.
When was SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC founded?
SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC was officially incorporated on 19 August 2025 and is registered under company number 16659770. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC?
Community Interest Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC?
SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC do?
SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC operates in the following sector: 88990 - Other social work activities without accommodation n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC's registered address?
The registered office address of SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC is 71-75 SHELTON STREET, LONDON, ENGLAND, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC financially stable?
Financial accounts for SYRIAN BIOTECH AND PHARMACEUTICAL SOCIETY (SBPS) CIC are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.